• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Hemorrhoids Treatment Market

    ID: MRFR/HC/14733-CR
    100 Pages
    Rahul Gotadki
    May 2024

    US Hemorrhoids Treatment Market Research Report Information by Type (External Hemorrhoids, Internal Hemorrhoids, Prolapsed Hemorrhoids), By Treatment Type (Surgical, Nonsurgical), By Specialist (Proctologist, General Physician, Gastroenterologist, Others) By End-User (Hospitals and Clinics, Ambulatory surgical centers, Others) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Hemorrhoids Treatment Market Infographic
    Purchase Options

    US Hemorrhoids Treatment Market Summary

    The US Hemorrhoids Treatment market is projected to grow from 1.67 USD Billion in 2024 to 2.74 USD Billion by 2035.

    Key Market Trends & Highlights

    US Hemorrhoids Treatment Key Trends and Highlights

    • The US Hemorrhoids Treatment market is valued at 1.67 USD Billion in 2024.
    • By 2035, the market is expected to reach 2.74 USD Billion, indicating a robust growth trajectory.
    • The market is anticipated to experience a compound annual growth rate (CAGR) of 4.6% from 2025 to 2035.
    • Growing adoption of advanced treatment options due to increasing awareness about hemorrhoid management is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.67 (USD Billion)
    2035 Market Size 2.74 (USD Billion)
    CAGR (2025-2035) 4.58%

    Major Players

    Medtronic Plc (Ireland), CONMED Corporation (US), Cook Medical (US), Pfizer Inc (US), Abbott Laboratories (US), Boston Scientific Corporation (US), Integra Life Sciences (US), Sklar Surgical Instruments (US), Privi Medical (US), Olympus Corporation (Japan)

    US Hemorrhoids Treatment Market Trends

    Increasing prevalence of hemorrhoids is expected to boost the market growth

    The U.S. hemorrhoid treatment market is currently undergoing a significant expansion, primarily fueled by the rising prevalence of hemorrhoids and a multitude of contributing factors. According to the US Department of Health and Human Services, the total number of people suffering from hemorrhoids in the United States is estimated to be around 10.4 million, with 1 million new cases diagnosed each year. Hemorrhoids, characterized by the swelling of veins in the rectum and anus, have become a pervasive health concern in the United States.

    This increase in prevalence can be attributed to several key factors, including contemporary lifestyle choices and dietary habits. The modern sedentary way of life, often characterized by prolonged periods of sitting, coupled with diets lacking in essential dietary fiber, has made hemorrhoids a more common affliction.

    In addition to awareness, ongoing research and development efforts have led to remarkable advancements in the field of hemorrhoid treatment. Minimally invasive procedures, innovative medications, and cutting-edge technologies have emerged as novel approaches to managing this condition. These advancements not only improve treatment outcomes but also contribute to the overall expansion of the market as patients and healthcare providers seek more effective and patient-friendly options. The availability of healthcare infrastructure and specialized medical professionals further catalyzes the market's growth. Access to healthcare facilities and clinics that offer hemorrhoid treatment options is essential for patients seeking relief from this condition.

    Moreover, Patients grappling with hemorrhoids prioritize treatments that offer relief from the pain and discomfort associated with the condition, ultimately enhancing their quality of life. The market is further bolstered by the presence of Over the Counter (OTC) products, such as creams, ointments, and suppositories, which provide convenient and accessible solutions for individuals looking to manage mild hemorrhoid symptoms independently.

    Market Segment Insights

    US Hemorrhoids Treatment Market Insights

    The US Hemorrhoids Treatment market segmentation, based on Type, includes External Hemorrhoids, Internal Hemorrhoids, and Prolapsed Hemorrhoids. The Internal Hemorrhoids segment is to hold the majority share in 2022 in the US Hemorrhoids Treatment market revenue. This is because of the aging population, there is an increasing prevalence of internal hemorrhoids, spurring demand for effective remedies. Heightened awareness and education contribute to a proactive approach among individuals seeking treatment. Advances in medical technologies and a trend favoring minimally invasive procedures, such as rubber band ligation and infrared coagulation, are shaping the landscape.

    Additionally, the availability of over-the-counter products underscores a broader market for self-management. Monitoring these trends will provide a comprehensive understanding of the evolving landscape of internal hemorrhoid treatments and their continued growth in the US.

    US Hemorrhoids Treatment Type Insights

    The US Hemorrhoids Treatment market segmentation is based on a Treatment Type, that includes Surgical, and nonsurgical. The non-surgical segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the rise of effective and convenient treatments, and the market's expansion is further supported by increased awareness, education, and the availability of over-the-counter products, creating a comprehensive landscape for managing hemorrhoids in the US.

    US Hemorrhoids Treatment Indication Insights

    The US Hemorrhoids Treatment market segmentation is based on a Specialist, that includes Proctologist, General Physician, Gastroenterologist, and Others. The Proctologist specialist segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the prevalence of hemorrhoids rising, especially among an aging population, and the demand for specialized care provided by proctologists is escalating. These specialists contribute significantly to the market's expansion by offering tailored and effective treatments, utilizing their expertise in both surgical and nonsurgical interventions.

    The increasing awareness of the importance of seeking specialized medical advice for hemorrhoid management further reinforces the market's growth trajectory in the United States.

    Figure 2: US HEMORRHOIDS TREATMENT MARKET, BY INDICATION, 2022 & 2032 (USD Billion)

    Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    US Hemorrhoids Treatment End User Insights

    The US Hemorrhoids Treatment market segmentation is based on end-user that Hospital & clinics, Ambulatory surgical centers, and Others. The hospital & clinics segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2024-2032. This is due to as the prevalence of hemorrhoids increases, these healthcare facilities serve as crucial hubs for diagnosis, treatment, and management. Specialized gastrointestinal units in hospitals and dedicated proctology services in clinics contribute significantly to the market's expansion.

    US Hemorrhoids Treatment Country Insights

    The US hemorrhoid treatment market is growing due to a rising prevalence of hemorrhoids, particularly among an aging demographic, and the demand for effective treatments is increasing. The market's trajectory is shaped by advancements in medical technologies, a trend towards less invasive procedures, and the expertise of proctologist specialists. Additionally, hospitals and clinics play a crucial role in providing comprehensive care, offering a range of treatment options, and contributing significantly to the market's expansion. Increased awareness, education, and the availability of over-the-counter products further bolster the growth of the hemorrhoids treatment market, creating a dynamic landscape in the United States.

    Get more detailed insights about US Hemorrhoids Treatment Market

    Key Players and Competitive Insights

    The US Hemorrhoids Treatment market is characterized by the presence of many players. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reached across the US with diverse Type portfolios. Companies such as Medtronic Plc (Ireland), Cook Medical, Pfizer Inc (US), Boston Scientific Corporation (US) are dominate the US Hemorrhoids Treatment market due to Type differentiation, financial stability, strategic services, and diversified regional presence. The players are focused on investing in extensive research and development as well.

    Furthermore, they adopt strategic growth initiatives, such as expansion, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.

    One of the primary business strategies adopted by manufacturers in the US hemorrhoid treatment industry to benefit clients and expand the healthcare counseling market sector is to manufacture locally to reduce operating costs.

    Key Companies in the US Hemorrhoids Treatment Market market include

    Industry Developments

    In June 2022, ProNova Partners (US), a mergers and acquisitions firm based in the United States, was permitted to assist in the sale of all rights to manufacture and sell a patented, painless, non-invasive device to eliminate hemorrhoids.

    In June 2022, Medtronic (Ireland) announced the launch of its new hemorrhoid treatment device, the HET Bipolar System, which treats internal hemorrhoids in a gentle, non-surgical manner. The system delivers bipolar energy to the hemorrhoid tissue, which causes coagulation and subsequent necrosis.

    Market Segmentation

    US Hemorrhoids Treatment Type Outlook

    • Surgical Hemorrhoidectomy Hemorrhoidal Stapling
    • Hemorrhoidectomy
    • Hemorrhoidal Stapling
    • Nonsurgical Medication Devices Band Ligators Sclerotherapy Injectors Infrared Coagulators Bipolar Probes Cryotherapy Devices Hemorrhoid Laser Probes Others
    • Medication
    • Devices Band Ligators Sclerotherapy Injectors Infrared Coagulators Bipolar Probes Cryotherapy Devices Hemorrhoid Laser Probes Others
    • Band Ligators
    • Sclerotherapy Injectors
    • Infrared Coagulators
    • Bipolar Probes
    • Cryotherapy Devices
    • Hemorrhoid Laser Probes
    • Others

    US Hemorrhoids Treatment End User Outlook

    • Hospital & clinics
    • Ambulatory surgical centers
    • Others

    US Hemorrhoids Treatment Specialist Outlook

    • Proctologist
    • General Physician
    • Gastroenterologist
    • Others

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024    1.67 (USD Billion)
    Market Size 2025    1.75 (USD Billion)
    Market Size 2035 2.74 (USD Billion)
    Compound Annual Growth Rate (CAGR) 4.58% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Type, Treatment Type, Specialist, End User, and Region
    Countries Covered US
    Key Companies Profiled Medtronic Plc (Ireland), CONMED Corporation (US) Cook Medical (US), Pfizer Inc (US), Abbott Laboratories (US), Boston Scientific Corporation (US), Integra LifeSciences (US), Sklar Surgical Instruments (US) Privi Medical (US), Olympus Corporation (Japan)  
    Key Market Opportunities ·       Innovation in hemorrhoid treatment devices ·       Consumer Awareness and Education
    Key Market Dynamics ·       Increasing prevalence of hemorrhoids ·       New approaches to treat hemorrhoids

    FAQs

    What is the projected growth of the US Hemorrhoids Treatment market?

    The US Hemorrhoids Treatment market is the expected increase in total market value of 2.74 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the US Hemorrhoids Treatment market?

    US Hemorrhoids Treatment market size was valued at approximately 1.67 billion USD in 2024. This figure will reach 2.74 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the US Hemorrhoids Treatment market?

    US Hemorrhoids Treatment market is expected to grow at a CAGR of 4.58% between 2025 and 2035.

    How much will the US Hemorrhoids Treatment market be worth by 2035?

    US Hemorrhoids Treatment market is expected to be worth of 2.74 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the US Hemorrhoids Treatment market perform over the next 10 years?

    Over the next 10 years the US Hemorrhoids Treatment market is expected to shift from usd billion 1.67 to 2.74 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials